The global fertility supplements market, valued at USD 2.30 billion in 2024, is entering a phase of strategic transformation, driven by innovation, consumer empowerment, and evidence-based product development. Key players such as Vitabiotics, Fairhaven Health, and Nature’s Way are capitalizing on rising demand for fertility vitamins, prenatal supplements, and herbal fertility supplements, offering formulations designed for specific reproductive needs. Consumers increasingly favor natural fertility supplements, fertility boosters, and ovulation support supplements, while digital channels enhance market education, brand engagement, and informed purchasing decisions. In India, a Total Fertility Rate of 2.0 in December 2024 reflects supportive initiatives like Mission Parivar Vikas, Antara injectable contraceptives, and PPIUCD services, illustrating the intersection of policy, healthcare infrastructure, and consumer adoption in shaping fertility trends.
Fertility Supplements overview
Published by MMR Statistics Research Team, Updated
